BOSTON, Aug. 11, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the expansion of its Scientific Advisory Board, appointing esteemed neuroscientist Robert Malenka, M.D., Ph.D., as well as experts in the development of neuroimmunology and T-cell therapeutics, Adam Boxer, M.D., Ph.D., Vijay Kuchroo, D.V.M., Ph.D., and Megan Levings, Ph.D., who have joined the AZTherapies SAB following the companys acquisition of Smith Therapeutics in October 2019.
We are very pleased to welcome these neuro-immunology leaders to our Scientific Advisory Board, as we are all committed to advancing efforts to slow down or halt the progression of neurodegenerative diseases by targeting neuroinflammation as the main cause of progressive neural damage, and declining cognition and function, said David R. Elmaleh, Ph.D., AZTherapies Founder, CEO, and Chairman. Each of our new board members brings unique expertise relevant to our pipeline whether it be our Phase 3 program in early Alzheimers disease, our progressing candidate for the treatment of ALS and post-ischemic stroke cognitive impairment, or our novel biologic approach using specifically engineered immunosuppressive CAR-T regulatory (Treg) cells to treat neurodegenerative disease and I look forward to working together to achieve our common goals.
Philip Ashton-Rickardt, Ph.D., Senior Vice President, Immunology at AZTherapies also commented on the appointments: I am thrilled that the SAB members from Smith have agreed to stay on to support our efforts in the development of CAR-Tregs to restore a healthy balance of inflammatory and regulatory cells in the brain. Since last fall, we have continued to advance this innovative program through pre-clinical development, and now anticipate initial in vitro and in vivo proof of concept across several models of neurodegenerative disease later this year.
Dr. Malenka is Deputy Director of the Wu Tsai Neurosciences Institute and Associate Chair of the Department of Psychiatry and Behavioral Science at Stanford University, while also serving as the Pritzker Professor of Psychiatry & Behavioral Sciences. Recognized as a world leader in the field of synapse biology, his work has resulted in more than 250 scientific publications. Dr. Malenka is an elected member of both the National Academy of Sciences and the National Academy of Medicine as well as the American Academy of Arts and Sciences. He received a B.A., summa cum laude, from Harvard College and an M.D. and a Ph.D. in neuroscience from Stanford University School of Medicine.
Dr. Boxer is Endowed Professor in Memory and Aging in the Department of Neurology at the University of California, San Francisco (UCSF) and directs UCSFs Neurosciences Clinical Research Unit and the Alzheimers Disease and Frontotemporal Degeneration (FTD) Clinical Trials Program at the UCSF Memory and Aging Center. Dr. Boxers research is focused on developing new treatments and biomarkers for neurodegenerative diseases. He is the principal investigator of the Advancing Research and Treatment for Frontotemporal Lobar Degeneration Clinical Research Consortium, while also leading the FTD Treatment Study Group, which is looking to speed the development of new therapies for FTD. The author of more than 150 scientific publications, Dr. Boxer received his medical and doctorate degrees at New York University Medical Center.
Dr. Kuchroo is the Samuel L. Wasserstrom professor of neurology at Harvard Medical School, and a senior scientist at Brigham and Womens Hospital. He is also a member of the Broad Institute, and a participant in a Klarman Cell Observatory project that focuses on T cell differentiation. He is the founding director of the Evergrande Center for Immunologic Diseases at Harvard Medical School and Brigham and Womens Hospital. Dr. Kuchroo obtained his degree in Veterinary Medicine from the College of Veterinary Medicine, Hisar, India, and subsequently specialized in pathology at the University of Queensland, Brisbane Australia, where he obtained a Ph.D. He is the recipient of the Fred Z. Eager Research Prize, the Javits Neuroscience Award by the NIH, the Ranbaxy Prize in Medical Research, the Nobel Laureate Peter Doherty Lecture/Prize, and was named Distinguished Eberly Lecturer.
Dr. Levings is Professor, Department of Surgery and School of Biomedical Engineering, Faculty of Medicine at the University of British Columbia, Investigator at BC Childrens Hospital Research Institute, Lead, Childhood Diseases Research Theme, and an Associate Member of the Department of Microbiology and Immunology. She is internationally recognized in the field of human immunology and currently chairs the Federation of Clinical Immunology Societies Centers' of Excellence and is a member of the NIH-funded Immune Tolerance Network steering committee. Her research focuses on the use of T regulatory cells to replace conventional immunosuppression in the context of transplantation and autoimmunity. Dr. Levings received her BSc in biology from Simon Fraser University and her Ph.D. in genetics at the University of British Columbia.
About AZTherapiesAZTherapies is an advanced clinical-stage biopharmaceutical company developing novel small molecules and biologic therapies that aim to fundamentally change neurodegenerative disease progression, extending normal cognition and function and improving quality of life in the aging population. Our lead candidate, ALZT-OP1, is built on a multi-modal approach that recognizes neuroinflammation as a root cause of serious neurodegeneration and seeks to stop or slow the progression of disease; the ALZT-OP1 Phase 3 COGNITE trial in early Alzheimers disease is fully enrolled, with trial completion expected in late 2020 and results in the first quarter of 2021. Following our lead program, we are advancing candidates for the treatment of amyotrophic lateral sclerosis (ALS), post-ischemic stroke cognitive impairment, and are pursuing an innovative CAR-Treg program that could have broad application across a spectrum of neurodegenerative diseases. AZTherapies is a private company headquartered in Boston, Massachusetts. To learn more, please visit http://www.aztherapies.com.
Media Contact:Jennifer LaVinjlavin@aztherapies.com
Investor Contact:Brian BartlettChief Financial & Accounting Officerbrian.bartlett@aztherapies.com
Here is the original post:
AZTherapies Announces the Appointment of Drs. Robert Malenka, Adam Boxer, Vijay Kuchroo and Megan Levings, to Scientific Advisory Board -...
- Cristina Savin and Tim Vogels discuss how AI has shaped their neuroscience research - The Transmitter: Neuroscience News and Perspectives - October 13th, 2024 [October 13th, 2024]
- Should I stay (and eat) or should I go? How the brain balances hunger with competing drives - The Transmitter: Neuroscience News and Perspectives - October 13th, 2024 [October 13th, 2024]
- How neuroscience comics add KA-POW! to the field: Q&A with Kanaka Rajan - The Transmitter: Neuroscience News and Perspectives - October 13th, 2024 [October 13th, 2024]
- Neuroscience research sheds light on how psilocybin alters spatial awareness - PsyPost - October 13th, 2024 [October 13th, 2024]
- Newly Discovered Protein Complex Shapes Synapses and Mental Health - Neuroscience News - October 13th, 2024 [October 13th, 2024]
- The Neuroscience Behind Immersive Filmmaking - Raindance - October 13th, 2024 [October 13th, 2024]
- What are mechanisms? Unpacking the term is key to progress in neuroscience - The Transmitter: Neuroscience News and Perspectives - October 13th, 2024 [October 13th, 2024]
- Kentucky neuroscience doctor honored with national distinction - wnky.com - October 13th, 2024 [October 13th, 2024]
- Cell X Technologies and Aspen Neuroscience collaborate to address throughput and scalability in manufacturing automation to facilitate iPSC cell... - October 13th, 2024 [October 13th, 2024]
- Tracking Daily Habits Lasting Effects on the Brain - Neuroscience News - October 13th, 2024 [October 13th, 2024]
- Dak Prescott Was Silent After Hearing It From a Teammate. Its a Lesson in Emotional Intelligence (Backed By Neuroscience) - Inc. - October 13th, 2024 [October 13th, 2024]
- Helping Kids Fact-Check in the Age of Misinformation - Neuroscience News - October 13th, 2024 [October 13th, 2024]
- Study Links Calorie Restriction to Longevity - Neuroscience News - October 13th, 2024 [October 13th, 2024]
- A Princeton Professor Walks into a Neuroscience Meeting -- Many Years Later It Leads to a Nobel Prize in Physics - TAPinto.net - October 13th, 2024 [October 13th, 2024]
- Try these neuroscience-backed tactics to train your brain to make better decisions - Fast Company - October 2nd, 2024 [October 2nd, 2024]
- Tips to navigate SfN as a trainee - The Transmitter: Neuroscience News and Perspectives - October 2nd, 2024 [October 2nd, 2024]
- Neuroscience Says This 10-Minute Brain Exercise Will Make You Mentally Sharper and Keep You Focused All Day - Inc. - October 2nd, 2024 [October 2nd, 2024]
- Successful people do this 1 thing to be 'happier, more productive, less stressed' at work, says CEO and neuroscience researcher - CNBC - October 2nd, 2024 [October 2nd, 2024]
- Utilizing the Power of Neuroscience, Isabella Kensington May Have Cracked the Code Between Music and Healing - AOL - October 2nd, 2024 [October 2nd, 2024]
- Steve Jobs swore the 10-minute rule made him smarter. Modern neuroscience is discovering he was right - The Star Online - October 2nd, 2024 [October 2nd, 2024]
- Steve Jobs Swore the 10-Minute Rule Made Him Smarter. Modern Neuroscience Is Discovering He Was Right - Inc. - October 2nd, 2024 [October 2nd, 2024]
- Neural manifolds: Latest buzzword or pathway to understand the brain? - The Transmitter: Neuroscience News and Perspectives - October 2nd, 2024 [October 2nd, 2024]
- Neuroscience Says 3 Brainy Habits Will Make You More Efficient, Productive, and Focused - Inc. - October 2nd, 2024 [October 2nd, 2024]
- Ethics, AI, and Neuroscience Converge at Mental Health, Brain, and Behavioral Science Research Day - The University of Utah - October 2nd, 2024 [October 2nd, 2024]
- The neuroscience of campus memories - The Stanford Daily - October 2nd, 2024 [October 2nd, 2024]
- How the Brain Enhances Sleep Through Synaptic Strength - Neuroscience News - October 2nd, 2024 [October 2nd, 2024]
- Neanderthoids and space brains: Stem cell researcher pushes the boundaries of neuroscience - Medical Xpress - October 2nd, 2024 [October 2nd, 2024]
- Nancy Padilla-Coreano - The Transmitter: Neuroscience News and Perspectives - October 2nd, 2024 [October 2nd, 2024]
- Utilizing the Power of Neuroscience, Isabella Kensington May Have Cracked the Code Between Music and Healing - Spin - October 2nd, 2024 [October 2nd, 2024]
- Genetic Variants Linked to Alzheimers Trigger Inflammation in Females - Neuroscience News - October 2nd, 2024 [October 2nd, 2024]
- New Astrocyte Target for Alzheimers Therapy - Neuroscience News - October 2nd, 2024 [October 2nd, 2024]
- Is an ankle sprain also a brain injury? How neuroscience is helping athletes, astronauts and average Joes - The Conversation Indonesia - October 2nd, 2024 [October 2nd, 2024]
- 5 Brain Strategies to Dramatically Reduce Conflict and Boost Your Leadership, Backed by Neuroscience - Inc. - September 23rd, 2024 [September 23rd, 2024]
- Fascinating neuroscience research reveals a key mechanism underlying human cognition - PsyPost - September 23rd, 2024 [September 23rd, 2024]
- Averaging is a convenient fiction of neuroscience - The Transmitter: Neuroscience News and Perspectives - September 23rd, 2024 [September 23rd, 2024]
- Repeat scans reveal brain changes that precede childbirth - The Transmitter: Neuroscience News and Perspectives - September 23rd, 2024 [September 23rd, 2024]
- Neuroscience helps explain the teenage brain and mental health - ABC News - September 15th, 2024 [September 15th, 2024]
- XX Marks the Spot: Addressing Sex Bias in Neuroscience - The Scientist - September 15th, 2024 [September 15th, 2024]
- Neuroscience-based tools for transformative leadership - Fast Company - September 15th, 2024 [September 15th, 2024]
- How 100 Years of EEG Have Transformed Neuroscience - Being Patient - September 15th, 2024 [September 15th, 2024]
- Reconstructing dopamines link to reward - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- The neuroscience of itch in relation to transdiagnostic psychological approaches - Nature.com - September 15th, 2024 [September 15th, 2024]
- A README for open neuroscience - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- Dopamine and the need for alternative theories - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- Kim Stachenfeld on the dance between neuroscience and artificial intelligence - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- Vijay Mohan K. Namboodiri - The Transmitter: Neuroscience News and Perspectives - September 15th, 2024 [September 15th, 2024]
- Varied Cognitive Training Boosts Learning and Memory - Neuroscience News - September 15th, 2024 [September 15th, 2024]
- Issue | September 2024 | XX Marks the Spot: Addressing Sex Bias in Neuroscience - The Scientist - September 15th, 2024 [September 15th, 2024]
- The Transmitter Partners With World Wide Neuro and Brain Inspired, Building on Mission to Inform, Connect Neuroscience Community - StreetInsider.com - September 15th, 2024 [September 15th, 2024]
- Gene Therapy Offers Hope for Glaucoma and AMD - Neuroscience News - September 15th, 2024 [September 15th, 2024]
- The Neuroscience of Phantom Sensations: Can We Feel Whats Not Really There? - SciTechDaily - September 2nd, 2024 [September 2nd, 2024]
- Tau May Protect Brain Cells from Oxidative Damage - Neuroscience News - September 2nd, 2024 [September 2nd, 2024]
- Scientists use fainting to uncover new insights into the neuroscience of consciousness - PsyPost - September 2nd, 2024 [September 2nd, 2024]
- Biosensors and being fearless with Lin Tian - The Transmitter: Neuroscience News and Perspectives - September 2nd, 2024 [September 2nd, 2024]
- Can Neuroscience Train Your Brain to Be Happier? This Startup Has an App for That - Inc. - September 2nd, 2024 [September 2nd, 2024]
- Neuroscience Surprise: Different Types of Love Light Up Different Parts of the Brain - SciTechDaily - September 2nd, 2024 [September 2nd, 2024]
- Second paper from lab of Nobel Prize winner to be retracted - The Transmitter: Neuroscience News and Perspectives - September 2nd, 2024 [September 2nd, 2024]
- How cognitive bias affects your draft strategy with neuroscience professor Dr. Renee Miller - Yahoo Sports - August 5th, 2024 [August 5th, 2024]
- This 3-step approach to performance reviews uses neuroscience to make them less awful - Fast Company - August 5th, 2024 [August 5th, 2024]
- Is it time to worry about brain chimeras? - The Transmitter: Neuroscience News and Perspectives - August 5th, 2024 [August 5th, 2024]
- Sharing brain images can foster new neuroscience discoveries - American Heart Association - July 26th, 2024 [July 26th, 2024]
- Latest News: Neuroscience Major Applies What Shes Learned in the Classroom and in the Lab - Muhlenberg College - July 26th, 2024 [July 26th, 2024]
- BioIVT to Highlight its Integral Role in Drug and Diagnostic Discovery and Development in addition to Neuroscience Research at Premier Life Science... - July 26th, 2024 [July 26th, 2024]
- Alto Neuroscience Receives Funding Award from Wellcome Trust to Accelerate Development of ALTO-100 in Bipolar Depression Leveraging Precision... - July 26th, 2024 [July 26th, 2024]
- Neuroscience Says 3 Simple Steps Can Turn Disappointment and Stress Into Success and Fulfillment (and Boost Your Emotional Intelligence) - Inc. - July 26th, 2024 [July 26th, 2024]
- Golf: neuroscience reveals the secrets of better putting new study - The Conversation - July 26th, 2024 [July 26th, 2024]
- The Neuroscience Behind Video: Why Video is the Most Effective Marketing Channel - StreamTV Insider - July 26th, 2024 [July 26th, 2024]
- Building an autism research registry: Q&A with Tony Charman - The Transmitter: Neuroscience News and Perspectives - July 26th, 2024 [July 26th, 2024]
- Adjusting Proteins Increases Ozempics Effectiveness - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Low-Calorie Diets Harm Athletes Performance and Health - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Reflective Thinking Boosts Teen Brain Resilience to Violence - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Neuroscience Says Olympians Like Simone Biles Use the Autopilot Trick to Achieve Peak Performance. So Can You - Inc. - July 18th, 2024 [July 18th, 2024]
- What well-being is (and isnt), according to neuroscience - Big Think - July 18th, 2024 [July 18th, 2024]
- Brain Areas Take Micro-Naps While the Rest Stays Awake - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Persistent protein pairing enables memories to last - The Transmitter: Neuroscience News and Perspectives - July 18th, 2024 [July 18th, 2024]
- AI Enhances Story Creativity but Risks Reducing Novelty - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Infection Brain Inflammation Triggers Muscle Weakness - Neuroscience News - July 18th, 2024 [July 18th, 2024]
- Alto Neuroscience, Inc. (NYSE:ANRO) Receives Average Rating of Buy from Analysts - Defense World - July 18th, 2024 [July 18th, 2024]
- 2024 Kavli Prize awarded for research on face-selective brain areas - The Transmitter: Neuroscience News and Perspectives - June 18th, 2024 [June 18th, 2024]
- Unlocking Flow: The Neuroscience of Creative Bliss - Neuroscience News - April 15th, 2024 [April 15th, 2024]